197 related articles for article (PubMed ID: 31386273)
1. An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate.
Kalaria SN; McElroy SL; Gobburu J; Gopalakrishnan M
Clin Transl Sci; 2020 Jan; 13(1):88-97. PubMed ID: 31386273
[TBL] [Abstract][Full Text] [Related]
2. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
Dalai SS; Adler S; Najarian T; Safer DL
Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
Safer DL; Adler S; Dalai SS; Bentley JP; Toyama H; Pajarito S; Najarian T
Int J Eat Disord; 2020 Feb; 53(2):266-277. PubMed ID: 31721257
[TBL] [Abstract][Full Text] [Related]
4. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
[TBL] [Abstract][Full Text] [Related]
6. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
Grilo CM; White MA
Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment of binge eating disorder: update review and synthesis.
Reas DL; Grilo CM
Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
[TBL] [Abstract][Full Text] [Related]
9. SipNose-topiramate: a potential novel approach to binge eating management.
Kobo-Greenhut A; Zohar-Beja A; Hadar L; Itzhaki L; Karasik A; Caraco Y; Frankenthal H; Shahaf D; Ekstein D; Shichor I; Gur E
J Eat Disord; 2023 Jun; 11(1):102. PubMed ID: 37365668
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
[TBL] [Abstract][Full Text] [Related]
11. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
[TBL] [Abstract][Full Text] [Related]
13. Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group.
Blom TJ; Mingione CJ; Guerdjikova AI; Keck PE; Welge JA; McElroy SL
Eur Eat Disord Rev; 2014 Mar; 22(2):140-6. PubMed ID: 24399652
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
[TBL] [Abstract][Full Text] [Related]
15. Armodafinil in binge eating disorder: a randomized, placebo-controlled trial.
McElroy SL; Guerdjikova AI; Mori N; Blom TJ; Williams S; Casuto LS; Keck PE
Int Clin Psychopharmacol; 2015 Jul; 30(4):209-15. PubMed ID: 26011779
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.
Guerdjikova AI; McElroy SL; Winstanley EL; Nelson EB; Mori N; McCoy J; Keck PE; Hudson JI
Int J Eat Disord; 2012 Mar; 45(2):281-9. PubMed ID: 21744377
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Treatments for Binge-Eating Disorder.
McElroy SL
J Clin Psychiatry; 2017; 78 Suppl 1():14-19. PubMed ID: 28125174
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of rimonabant in obese patients with binge eating disorder.
Pataky Z; Gasteyger C; Ziegler O; Rissanen A; Hanotin C; Golay A
Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):20-6. PubMed ID: 23147209
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
[TBL] [Abstract][Full Text] [Related]
20. Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study.
Corwin RL; Boan J; Peters KF; Ulbrecht JS
Behav Pharmacol; 2012 Sep; 23(5-6):616-25. PubMed ID: 22854310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
